Abstract Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profiles and outcome features. However, the extent of neuroanatomical heterogeneity in the CHR-P state is largely undetermined. We aimed to quantify the neuroanatomical heterogeneity in structural magnetic resonance imaging measures of cortical surface area (SA), cortical thickness (CT), subcortical volume (SV), and intracranial volume (ICV) in CHR-P individuals compared with healthy controls (HC), and in relation to subsequent transition to a first episode of psychosis. The ENIGMA CHR-P consortium applied a harmonised analysis to neuroimaging data across 29 international sites, including 1579 CHR-P individuals and 1243 HC, offering the la...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...
Individuals at Clinical High Risk for Psychosis (CHR-P) demonstrate heterogeneity in clinical profil...